搜索临床试验以:Sacubitril-Valsartan 49 Mg-51 Mg 口服片剂
总计623个结果
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)招聘中心血管疾病 | 高血压 | 肥胖 | 夜间血压 | 利钠肽 | 肾素-血管紧张素-醛固酮系统美国
-
Instituto Nacional de Cardiologia Ignacio ChavezBoehringer Ingelheim laboratory尚未招聘
-
Massachusetts General Hospital招聘中
-
Guangdong Provincial People's Hospital未知
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Mayo ClinicNational Institute on Aging (NIA)完全的
-
Ohio State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)主动,不招人
-
University Hospital, Grenoble招聘中
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United Kingdom招聘中
-
University of Milan尚未招聘
-
Cara Therapeutics, Inc.终止慢性肾脏病 | 瘙痒症美国, 匈牙利, 澳大利亚, 德国, 大韩民国, 波兰, 阿根廷, 巴西, 保加利亚, 意大利, 墨西哥, 罗马尼亚, 西班牙
-
Jacob MollerOdense University Hospital; Rigshospitalet, Denmark; Danish Heart Foundation招聘中
-
AgeneBioNational Institute on Aging (NIA)完全的
-
Shenzhen Second People's Hospital招聘中
-
Germans Trias i Pujol Hospital完全的
-
Ain Shams UniversityCairo University招聘中
-
University of Alabama at BirminghamEli Lilly and Company尚未招聘
-
Institute of Hematology & Blood Diseases Hospital尚未招聘鲁索替尼对 AA HSCT 受者的 aGVHD 的预防价值
-
Enteris BioPharma Inc.Syneos Health; Parexel招聘中
-
Ilkos Therapeutic Inc.完全的
-
Montreal Heart InstituteNovartis Pharmaceuticals终止
-
Axsome Therapeutics, Inc.完全的
-
Immunic AG主动,不招人
-
Daewoong Pharmaceutical Co. LTD.完全的